Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
- 1 January 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Advances in Anatomic Pathology
- Vol. 20 (1) , 32-38
Abstract
Heterozygous hotspot mutations in isocitrate dehydrogenases (IDH) IDH1 or IDH2 are frequently observed in specific types of cartilaginous tumors, gliomas, and leukemias. Mutant IDH enzyme loses its normal activity to convert isocitrate into α-ketoglutarate (αKG) and instead acquires the ability to reduce αKG to D-2-hydroxyglutarate. Through direct competition with αKG, accumulation of the oncometabolite D-2-hydroxyglutarate in IDH mutated tumors results in inhibition of αKG-dependent dioxygenases involved in DNA and histone demethylation. Apart from epigenetic alterations, perturbations in the tricarboxylic acid cycle (depletion of intermediates) and activation of the intricately linked hypoxia signaling pathway are apparent in IDH mutated cells. As molecular details are being unraveled, the emerging concept is that IDH mutations result in tumor formation by epigenetic alterations that affect gene expression and result in inhibition of cellular differentiation. Activation of hypoxic stress signaling reprograms cellular energy metabolism and promotes anabolic processes and angiogenesis, thus, providing an advantage to promote neoplastic growth.Keywords
This publication has 80 references indexed in Scilit:
- Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during TumorigenesisPLOS Genetics, 2012
- Cancer-Associated Isocitrate Dehydrogenase MutationsThe Oncologist, 2012
- The Warburg effect in 2012Current Opinion in Oncology, 2012
- Revisiting the TCA cycle: signaling to tumor formationTrends in Molecular Medicine, 2011
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursThe Journal of Pathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?Current Opinion in Genetics & Development, 2010
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- On the Origin of Cancer CellsScience, 1956